Show simple item record

dc.contributor.authorvan der Graaf, WTA
dc.date.accessioned2017-04-21T16:54:24Z
dc.date.issued2016-07
dc.identifier.citationLancet (London, England), 2016, 388 (10043), pp. 442 - 444
dc.identifier.issn0140-6736
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/617
dc.identifier.eissn1474-547X
dc.identifier.doi10.1016/s0140-6736(16)30788-7
dc.formatPrint-Electronic
dc.format.extent442 - 444
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectSarcoma
dc.subjectSoft Tissue Neoplasms
dc.titleOlaratumab in soft-tissue sarcomas.
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/s0140-6736(16)30788-7
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-07
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfLancet (London, England)
pubs.issue10043
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.publication-statusPublished
pubs.volume388
pubs.embargo.termsNot known
icr.researchteamClinical and Translational Sarcomaen_US
dc.contributor.icrauthorvan der Graaf, Wilhelmina


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record